At the 2026 Innovative Drug High Quality Development Conference held in Suzhou, Jiangsu Province this morning, Huang Xinyu, director of the Pharmaceutical Service Management Department of the National Health Insurance Administration, explained that by the end of October this year, 19 drugs in the “Commercial Health Insurance Innovative Drug Catalogue” had been distributed in 1,710 medical institutions and designated retail pharmacies. The total number of drug users was nearly 30,000, driving drug sales of about 600 million yuan. The number of equipped institutions increased by about 140% compared to before being included in the catalogue, and sales increased 70% in a single month. Two of these drugs were successfully included in the national medical insurance drug catalogue this year, achieving a transformation path of pioneering exploration of innovative drug commercial insurance and timely integration of basic medical insurance.

Zhitongcaijing · 1d ago
At the 2026 Innovative Drug High Quality Development Conference held in Suzhou, Jiangsu Province this morning, Huang Xinyu, director of the Pharmaceutical Service Management Department of the National Health Insurance Administration, explained that by the end of October this year, 19 drugs in the “Commercial Health Insurance Innovative Drug Catalogue” had been distributed in 1,710 medical institutions and designated retail pharmacies. The total number of drug users was nearly 30,000, driving drug sales of about 600 million yuan. The number of equipped institutions increased by about 140% compared to before being included in the catalogue, and sales increased 70% in a single month. Two of these drugs were successfully included in the national medical insurance drug catalogue this year, achieving a transformation path of pioneering exploration of innovative drug commercial insurance and timely integration of basic medical insurance.